Technology | Angiography | March 01, 2019

iSchemaView Launches RAPID Angio

iSchemaView partners with Siemens Healthineers to integrate the RAPID platform with syngo DynaCT to deliver a complete stroke imaging solution for the angio suite

iSchemaView Launches RAPID Angio

March 1, 2019 — iSchemaView announced the release of RAPID Angio, a complete neuroimaging solution for the angiography suite that integrates iSchemaView’s RAPID software with syngo DynaCT Multiphase from Siemens Healthineers. The syngo DynaCT Multiphase is a three-dimensional image acquisition technique employing multiple rotations of a C-arm system to acquire a multi-phasic 3-D representation of the brain and its perfusion. This technology, when combined with the RAPID platform’s CTP product, delivers a powerful imaging solution to the angio suite for acute stroke patients.

The RAPID Angio module, by combining the syngo DynaCT system with the RAPID platform, allows for the direct evaluation of acute stroke patients in the angiography procedure room, saving precious time. The RAPID platform automatically provides clear, easy-to-interpret computed tomography (CT) perfusion maps that readily identify brain regions with reduced cerebral blood flow and blood volume as well as delayed contrast arrival. It is the only neuroimaging platform that is U.S. Food and Drug Administration (FDA)-cleared for a thrombectomy indication. In addition to identifying irreversibly damaged brain tissue and salvageable areas, the CTP module includes hypoperfusion intensity ratio (HIR) and cerebral blood volume (CBV) indices for the assessment of collateral blood flow and the rate of infarct growth, as well as a “golden hour” index for ultra-early patients. RAPID CTP helps physicians with patient triage and clinical decision making.

“RAPID directly in the angio suite will help our specialists treat the right patients even faster,” said Prof. Jian Ming Liu, director of Neurosurgery Center, Changhai Hospital, China. “Having the most advanced RAPID technology available in both the radiology department and the operating theater provides the best options for our doctors and patients.”

RAPID Angio runs on the RAPID artificial intelligence (AI) framework. Developed by leading stroke experts, the RAPID AI framework combines deep learning, machine learning and expert feature extraction. Together these provide high sensitivity and specificity across stroke modules. Results are then delivered by the RAPID Intelligence Services Platform via picture archiving and communication system (PACS), email, text, the RAPID App or corporate partner workflow systems.

For more information: www.i-rapid.com, www.usa.healthcare.siemens.com

Related Content

A patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D. 

A patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D. 

News | Computed Tomography (CT) | February 10, 2020
February 10, 2020 — The U.S.
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Carestream’s X-ray digital tomosynthesis functionality creates three-dimensional datasets from digital radiography (DR) that can be scrolled through similar to computed tomography (CT) imaging. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2020. Digital tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation.
News | Digital Radiography (DR) | January 15, 2020
January 15, 2020 — Carestream’s X-ray digital tomosynthesis (DT) functionality, which creates three-dimensional datas
Videos | Advanced Visualization | December 30, 2019
This is a hologram of a fracture from a...
Feinstein Institutes' Thomas Chaly, Ph.D., poses in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

Feinstein Institutes' Thomas Chaly, Ph.D., in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

News | Nuclear Imaging | December 26, 2019
December 26, 2019 — The Feinstein Institutes for Medical R...
Videos | RSNA | December 18, 2019
ITN Editor Dave Fornell and ITN Consulting Editor Greg Freiherr offer a post-game report on the trends and technologi